Assembly Biosciences (NASDAQ:ASMB – Get Free Report) is one of 897 publicly-traded companies in the “Pharmaceuticals” industry, but how does it contrast to its rivals? We will compare Assembly Biosciences to related companies based on the strength of its earnings, dividends, valuation, analyst recommendations, risk, institutional ownership and profitability. Institutional and Insider Ownership 19.9% of […]